I tumori gastrointestinali stromali (GIST): Aspetti oncologici

Translated title of the contribution: Gastrointestinal Stromal Tumor (GIST): Oncological topics

Research output: Contribution to journalArticle

Abstract

Gastrointestinal stromal tumor is a disease increasingly identified during routine endoscopic procedures. The disease is potentially malignant regardless of its size. Its recognition should prompt surgical resection. Chemotherapy with Imatinib mesilate should be indicated for patients with unresectable GIST or after surgery if there is evidence of residual disease.

Original languageItalian
Pages (from-to)113-118
Number of pages6
JournalGiornale Italiano di Endoscopia Digestiva
Volume30
Issue number2
StatePublished - Jun 2007

Fingerprint

Gastrointestinal Stromal Tumors
Mesylates
Drug Therapy

Keywords

  • Endosonography
  • GIST

ASJC Scopus subject areas

  • Gastroenterology

Cite this

I tumori gastrointestinali stromali (GIST) : Aspetti oncologici. / Raimondo, Massimo.

In: Giornale Italiano di Endoscopia Digestiva, Vol. 30, No. 2, 06.2007, p. 113-118.

Research output: Contribution to journalArticle

@article{3a3559b8de4746c1ad53bd0ff78e88c5,
title = "I tumori gastrointestinali stromali (GIST): Aspetti oncologici",
abstract = "Gastrointestinal stromal tumor is a disease increasingly identified during routine endoscopic procedures. The disease is potentially malignant regardless of its size. Its recognition should prompt surgical resection. Chemotherapy with Imatinib mesilate should be indicated for patients with unresectable GIST or after surgery if there is evidence of residual disease.",
keywords = "Endosonography, GIST",
author = "Massimo Raimondo",
year = "2007",
month = "6",
language = "Italian",
volume = "30",
pages = "113--118",
journal = "Giornale Italiano di Endoscopia Digestiva",
issn = "0394-0225",
publisher = "Area Qualita Srl",
number = "2",

}

TY - JOUR

T1 - I tumori gastrointestinali stromali (GIST)

T2 - Aspetti oncologici

AU - Raimondo, Massimo

PY - 2007/6

Y1 - 2007/6

N2 - Gastrointestinal stromal tumor is a disease increasingly identified during routine endoscopic procedures. The disease is potentially malignant regardless of its size. Its recognition should prompt surgical resection. Chemotherapy with Imatinib mesilate should be indicated for patients with unresectable GIST or after surgery if there is evidence of residual disease.

AB - Gastrointestinal stromal tumor is a disease increasingly identified during routine endoscopic procedures. The disease is potentially malignant regardless of its size. Its recognition should prompt surgical resection. Chemotherapy with Imatinib mesilate should be indicated for patients with unresectable GIST or after surgery if there is evidence of residual disease.

KW - Endosonography

KW - GIST

UR - http://www.scopus.com/inward/record.url?scp=34447647283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447647283&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:34447647283

VL - 30

SP - 113

EP - 118

JO - Giornale Italiano di Endoscopia Digestiva

JF - Giornale Italiano di Endoscopia Digestiva

SN - 0394-0225

IS - 2

ER -